CM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| A Complexity Lens on the COVID-19 Pandemic | International journal of health policy and management |  | 2021 | 429 | 281 | ||
| Surveillance of resistance to new antibiotics in an era of limited treatment options | Frontiers in medicine | | 2021 | 183 | 81 | ||
| Governance in the age of complexity: building resilience to COVID-19 and future pandemics | | 2021 | 604 | 257 | |||
| A one health framework to estimate the cost of antimicrobial resistance | Antimicrobial resistance and infection control | | 2020 | 156 | 37 | ||
| Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus | The Journal of Antibiotics | | 2020 | 181 | 88 | ||
| Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation Incentives | The Journal of Law, Medicine & Ethics |  | 2018 | 345 | 0 | ||
| Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry? | Antibiotics | | 2018 | 289 | 120 | ||
| Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review | Intensive Care Medicine | | 2018 | 721 | 3 | ||
| Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality | PLoS medicine | | 2016 | 447 | 213 | ||
| International cooperation to improve access to and sustain effectiveness of antimicrobials | Lancet | | 2016 | 529 | 2 |
